Skip to content. | Skip to navigation

Agenus acquires from Diatheva s.r.l., an Italian biothech company controlled by SOL S.p.A., novel antibodies to Immuno-oncology Target CEACAM1

Agenus acquires from Diatheva s.r.l., an Italian biothech company controlled by SOL S.p.A., novel antibodies to Immuno-oncology Target CEACAM1

PDF document icon v 20.07.2015_PR diatheva Agenus _ENG.pdf — PDF document, 105 KB (108450 bytes)